Know Cancer

or
forgot password

Immuno-enhanced Versus Standard Early Enteral Nutrition Use in Gastrointestinal Postoperative Patients


Phase 4
18 Years
75 Years
Not Enrolling
Both
Gastrointestinal Malignant

Thank you

Trial Information

Immuno-enhanced Versus Standard Early Enteral Nutrition Use in Gastrointestinal Postoperative Patients


Inclusion Criteria:



- Resectable gastric cancer by laparoscope

- Resectable colorectal cancer laparoscope

- Resectable gastrointestinal interstitialoma by laparoscope

Exclusion Criteria:

- Locally unresectable tumor

- Metastatic tumor

- Preoperative total parenteral or enteral nutrition

- Lack of the patient's consent for the trial participation

- Previous gastrointestinal resection

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Time to tolerate IEEN/SEEN

Outcome Time Frame:

30 days after operation

Safety Issue:

No

Principal Investigator

Danhua Yao, MD/PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Nanjing University

Authority:

China: Ministry of Health

Study ID:

ISEEN001

NCT ID:

NCT01778166

Start Date:

February 2013

Completion Date:

March 2014

Related Keywords:

  • Gastrointestinal Malignant
  • Early enteral nutrition
  • Laparoscopic gastrointestinal surgery
  • Immuno-enhanced nutrition

Name

Location